The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Animal Orthopedic Diseases Stem Cell Therapy Market Research Report 2025

Global Animal Orthopedic Diseases Stem Cell Therapy Market Research Report 2025

Publishing Date : Apr, 2025

License Type :
 

Report Code : 2002877

No of Pages : 100

Synopsis
The global market for Animal Orthopedic Diseases Stem Cell Therapy was valued at US$ 270 million in the year 2024 and is projected to reach a revised size of US$ 738 million by 2031, growing at a CAGR of 15.5% during the forecast period.
Animal orthopedic diseases stem cell therapy refers to a regenerative medicine technique that utilizes the self-renewal and multipotent differentiation potential of stem cells to repair or replace damaged tissues such as bones, cartilage, and muscles, in order to treat animal orthopedic diseases. Stem cell sources include embryonic stem cells, adult stem cells (such as mesenchymal stem cells), etc., which have low immunogenicity and good tissue compatibility, and can promote tissue regeneration and functional recovery.
The global market size of stem cell therapy for orthopedic diseases in animals has shown a significant growth trend in recent years. With the rise of the pet economy, pet owners' attention to animal health has significantly increased, driving the demand for the application of stem cell therapy in pet orthopedic diseases. The application of stem cell therapy technology in orthopedic diseases is constantly maturing, especially in the clinical effects of cartilage defects, bone defects, and femoral head necrosis. The support policies of governments around the world for regenerative medicine and the continuous investment of capital provide strong guarantees for the development of the industry. The main participants in the global market for stem cell therapy for orthopedic diseases in animals include biotechnology companies, research institutions, and animal medical institutions. For example, companies such as MediVet Biologics, Regeneus, VetStem, etc. have a leading position in the field of animal stem cell therapy. In China, companies such as BION Biotechnology and Vetcell are also actively expanding into the animal stem cell therapy market. The challenges and risks of the market lie in technological barriers, ethical and safety issues, and incomplete regulatory policies in some regions. In the future, with the development of gene editing technology and 3D bioprinting technology, the precision and efficiency of stem cell therapy will be further improved. Stem cell therapy will not be limited to the pet market, but may also expand to the fields of animal husbandry and wildlife conservation.
This report aims to provide a comprehensive presentation of the global market for Animal Orthopedic Diseases Stem Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal Orthopedic Diseases Stem Cell Therapy.
The Animal Orthopedic Diseases Stem Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Animal Orthopedic Diseases Stem Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Animal Orthopedic Diseases Stem Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
MediVet Biologics
Regeneus
VetStem
Tissue Regeneration
ZyGenesis
Vetsuisse
Regenesis Biomedical
Cegelec
Boehringer Ingelheim
Astellas Pharma
Aratana Therapeutics
Neogen
Kite Pharma
Juno Therapeutics
Tianjin BION Biotechnology
Amazing Pet
Vetcell
Boya Life
Segment by Type
Totipotent Stem Cells
Pluripotent Stem Cells
Unipotent Stem Cells
Segment by Application
Osteoarthritis
Cartilage Injury
Fracture Repair
Femoral Head Necrosis
Spinal Degenerative Diseases
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Animal Orthopedic Diseases Stem Cell Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Animal Orthopedic Diseases Stem Cell Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Totipotent Stem Cells
1.2.3 Pluripotent Stem Cells
1.2.4 Unipotent Stem Cells
1.3 Market by Application
1.3.1 Global Animal Orthopedic Diseases Stem Cell Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Osteoarthritis
1.3.3 Cartilage Injury
1.3.4 Fracture Repair
1.3.5 Femoral Head Necrosis
1.3.6 Spinal Degenerative Diseases
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Animal Orthopedic Diseases Stem Cell Therapy Market Perspective (2020-2031)
2.2 Global Animal Orthopedic Diseases Stem Cell Therapy Growth Trends by Region
2.2.1 Global Animal Orthopedic Diseases Stem Cell Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Animal Orthopedic Diseases Stem Cell Therapy Historic Market Size by Region (2020-2025)
2.2.3 Animal Orthopedic Diseases Stem Cell Therapy Forecasted Market Size by Region (2026-2031)
2.3 Animal Orthopedic Diseases Stem Cell Therapy Market Dynamics
2.3.1 Animal Orthopedic Diseases Stem Cell Therapy Industry Trends
2.3.2 Animal Orthopedic Diseases Stem Cell Therapy Market Drivers
2.3.3 Animal Orthopedic Diseases Stem Cell Therapy Market Challenges
2.3.4 Animal Orthopedic Diseases Stem Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Animal Orthopedic Diseases Stem Cell Therapy Players by Revenue
3.1.1 Global Top Animal Orthopedic Diseases Stem Cell Therapy Players by Revenue (2020-2025)
3.1.2 Global Animal Orthopedic Diseases Stem Cell Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Top Animal Orthopedic Diseases Stem Cell Therapy Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Animal Orthopedic Diseases Stem Cell Therapy Revenue
3.4 Global Animal Orthopedic Diseases Stem Cell Therapy Market Concentration Ratio
3.4.1 Global Animal Orthopedic Diseases Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Animal Orthopedic Diseases Stem Cell Therapy Revenue in 2024
3.5 Global Key Players of Animal Orthopedic Diseases Stem Cell Therapy Head office and Area Served
3.6 Global Key Players of Animal Orthopedic Diseases Stem Cell Therapy, Product and Application
3.7 Global Key Players of Animal Orthopedic Diseases Stem Cell Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Animal Orthopedic Diseases Stem Cell Therapy Breakdown Data by Type
4.1 Global Animal Orthopedic Diseases Stem Cell Therapy Historic Market Size by Type (2020-2025)
4.2 Global Animal Orthopedic Diseases Stem Cell Therapy Forecasted Market Size by Type (2026-2031)
5 Animal Orthopedic Diseases Stem Cell Therapy Breakdown Data by Application
5.1 Global Animal Orthopedic Diseases Stem Cell Therapy Historic Market Size by Application (2020-2025)
5.2 Global Animal Orthopedic Diseases Stem Cell Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Animal Orthopedic Diseases Stem Cell Therapy Market Size (2020-2031)
6.2 North America Animal Orthopedic Diseases Stem Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Animal Orthopedic Diseases Stem Cell Therapy Market Size by Country (2020-2025)
6.4 North America Animal Orthopedic Diseases Stem Cell Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Animal Orthopedic Diseases Stem Cell Therapy Market Size (2020-2031)
7.2 Europe Animal Orthopedic Diseases Stem Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Animal Orthopedic Diseases Stem Cell Therapy Market Size by Country (2020-2025)
7.4 Europe Animal Orthopedic Diseases Stem Cell Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Animal Orthopedic Diseases Stem Cell Therapy Market Size (2020-2031)
8.2 Asia-Pacific Animal Orthopedic Diseases Stem Cell Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Animal Orthopedic Diseases Stem Cell Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Animal Orthopedic Diseases Stem Cell Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Animal Orthopedic Diseases Stem Cell Therapy Market Size (2020-2031)
9.2 Latin America Animal Orthopedic Diseases Stem Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Animal Orthopedic Diseases Stem Cell Therapy Market Size by Country (2020-2025)
9.4 Latin America Animal Orthopedic Diseases Stem Cell Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Animal Orthopedic Diseases Stem Cell Therapy Market Size (2020-2031)
10.2 Middle East & Africa Animal Orthopedic Diseases Stem Cell Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Animal Orthopedic Diseases Stem Cell Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Animal Orthopedic Diseases Stem Cell Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 MediVet Biologics
11.1.1 MediVet Biologics Company Details
11.1.2 MediVet Biologics Business Overview
11.1.3 MediVet Biologics Animal Orthopedic Diseases Stem Cell Therapy Introduction
11.1.4 MediVet Biologics Revenue in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025)
11.1.5 MediVet Biologics Recent Development
11.2 Regeneus
11.2.1 Regeneus Company Details
11.2.2 Regeneus Business Overview
11.2.3 Regeneus Animal Orthopedic Diseases Stem Cell Therapy Introduction
11.2.4 Regeneus Revenue in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025)
11.2.5 Regeneus Recent Development
11.3 VetStem
11.3.1 VetStem Company Details
11.3.2 VetStem Business Overview
11.3.3 VetStem Animal Orthopedic Diseases Stem Cell Therapy Introduction
11.3.4 VetStem Revenue in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025)
11.3.5 VetStem Recent Development
11.4 Tissue Regeneration
11.4.1 Tissue Regeneration Company Details
11.4.2 Tissue Regeneration Business Overview
11.4.3 Tissue Regeneration Animal Orthopedic Diseases Stem Cell Therapy Introduction
11.4.4 Tissue Regeneration Revenue in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025)
11.4.5 Tissue Regeneration Recent Development
11.5 ZyGenesis
11.5.1 ZyGenesis Company Details
11.5.2 ZyGenesis Business Overview
11.5.3 ZyGenesis Animal Orthopedic Diseases Stem Cell Therapy Introduction
11.5.4 ZyGenesis Revenue in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025)
11.5.5 ZyGenesis Recent Development
11.6 Vetsuisse
11.6.1 Vetsuisse Company Details
11.6.2 Vetsuisse Business Overview
11.6.3 Vetsuisse Animal Orthopedic Diseases Stem Cell Therapy Introduction
11.6.4 Vetsuisse Revenue in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025)
11.6.5 Vetsuisse Recent Development
11.7 Regenesis Biomedical
11.7.1 Regenesis Biomedical Company Details
11.7.2 Regenesis Biomedical Business Overview
11.7.3 Regenesis Biomedical Animal Orthopedic Diseases Stem Cell Therapy Introduction
11.7.4 Regenesis Biomedical Revenue in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025)
11.7.5 Regenesis Biomedical Recent Development
11.8 Cegelec
11.8.1 Cegelec Company Details
11.8.2 Cegelec Business Overview
11.8.3 Cegelec Animal Orthopedic Diseases Stem Cell Therapy Introduction
11.8.4 Cegelec Revenue in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025)
11.8.5 Cegelec Recent Development
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Details
11.9.2 Boehringer Ingelheim Business Overview
11.9.3 Boehringer Ingelheim Animal Orthopedic Diseases Stem Cell Therapy Introduction
11.9.4 Boehringer Ingelheim Revenue in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025)
11.9.5 Boehringer Ingelheim Recent Development
11.10 Astellas Pharma
11.10.1 Astellas Pharma Company Details
11.10.2 Astellas Pharma Business Overview
11.10.3 Astellas Pharma Animal Orthopedic Diseases Stem Cell Therapy Introduction
11.10.4 Astellas Pharma Revenue in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025)
11.10.5 Astellas Pharma Recent Development
11.11 Aratana Therapeutics
11.11.1 Aratana Therapeutics Company Details
11.11.2 Aratana Therapeutics Business Overview
11.11.3 Aratana Therapeutics Animal Orthopedic Diseases Stem Cell Therapy Introduction
11.11.4 Aratana Therapeutics Revenue in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025)
11.11.5 Aratana Therapeutics Recent Development
11.12 Neogen
11.12.1 Neogen Company Details
11.12.2 Neogen Business Overview
11.12.3 Neogen Animal Orthopedic Diseases Stem Cell Therapy Introduction
11.12.4 Neogen Revenue in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025)
11.12.5 Neogen Recent Development
11.13 Kite Pharma
11.13.1 Kite Pharma Company Details
11.13.2 Kite Pharma Business Overview
11.13.3 Kite Pharma Animal Orthopedic Diseases Stem Cell Therapy Introduction
11.13.4 Kite Pharma Revenue in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025)
11.13.5 Kite Pharma Recent Development
11.14 Juno Therapeutics
11.14.1 Juno Therapeutics Company Details
11.14.2 Juno Therapeutics Business Overview
11.14.3 Juno Therapeutics Animal Orthopedic Diseases Stem Cell Therapy Introduction
11.14.4 Juno Therapeutics Revenue in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025)
11.14.5 Juno Therapeutics Recent Development
11.15 Tianjin BION Biotechnology
11.15.1 Tianjin BION Biotechnology Company Details
11.15.2 Tianjin BION Biotechnology Business Overview
11.15.3 Tianjin BION Biotechnology Animal Orthopedic Diseases Stem Cell Therapy Introduction
11.15.4 Tianjin BION Biotechnology Revenue in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025)
11.15.5 Tianjin BION Biotechnology Recent Development
11.16 Amazing Pet
11.16.1 Amazing Pet Company Details
11.16.2 Amazing Pet Business Overview
11.16.3 Amazing Pet Animal Orthopedic Diseases Stem Cell Therapy Introduction
11.16.4 Amazing Pet Revenue in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025)
11.16.5 Amazing Pet Recent Development
11.17 Vetcell
11.17.1 Vetcell Company Details
11.17.2 Vetcell Business Overview
11.17.3 Vetcell Animal Orthopedic Diseases Stem Cell Therapy Introduction
11.17.4 Vetcell Revenue in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025)
11.17.5 Vetcell Recent Development
11.18 Boya Life
11.18.1 Boya Life Company Details
11.18.2 Boya Life Business Overview
11.18.3 Boya Life Animal Orthopedic Diseases Stem Cell Therapy Introduction
11.18.4 Boya Life Revenue in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025)
11.18.5 Boya Life Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
List of Tables
Table 1. Global Animal Orthopedic Diseases Stem Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Totipotent Stem Cells
Table 3. Key Players of Pluripotent Stem Cells
Table 4. Key Players of Unipotent Stem Cells
Table 5. Global Animal Orthopedic Diseases Stem Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Animal Orthopedic Diseases Stem Cell Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Animal Orthopedic Diseases Stem Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Animal Orthopedic Diseases Stem Cell Therapy Market Share by Region (2020-2025)
Table 9. Global Animal Orthopedic Diseases Stem Cell Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Animal Orthopedic Diseases Stem Cell Therapy Market Share by Region (2026-2031)
Table 11. Animal Orthopedic Diseases Stem Cell Therapy Market Trends
Table 12. Animal Orthopedic Diseases Stem Cell Therapy Market Drivers
Table 13. Animal Orthopedic Diseases Stem Cell Therapy Market Challenges
Table 14. Animal Orthopedic Diseases Stem Cell Therapy Market Restraints
Table 15. Global Animal Orthopedic Diseases Stem Cell Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Animal Orthopedic Diseases Stem Cell Therapy Market Share by Players (2020-2025)
Table 17. Global Top Animal Orthopedic Diseases Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal Orthopedic Diseases Stem Cell Therapy as of 2024)
Table 18. Ranking of Global Top Animal Orthopedic Diseases Stem Cell Therapy Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Animal Orthopedic Diseases Stem Cell Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Animal Orthopedic Diseases Stem Cell Therapy, Headquarters and Area Served
Table 21. Global Key Players of Animal Orthopedic Diseases Stem Cell Therapy, Product and Application
Table 22. Global Key Players of Animal Orthopedic Diseases Stem Cell Therapy, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Animal Orthopedic Diseases Stem Cell Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Animal Orthopedic Diseases Stem Cell Therapy Revenue Market Share by Type (2020-2025)
Table 26. Global Animal Orthopedic Diseases Stem Cell Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Animal Orthopedic Diseases Stem Cell Therapy Revenue Market Share by Type (2026-2031)
Table 28. Global Animal Orthopedic Diseases Stem Cell Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Animal Orthopedic Diseases Stem Cell Therapy Revenue Market Share by Application (2020-2025)
Table 30. Global Animal Orthopedic Diseases Stem Cell Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Animal Orthopedic Diseases Stem Cell Therapy Revenue Market Share by Application (2026-2031)
Table 32. North America Animal Orthopedic Diseases Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Animal Orthopedic Diseases Stem Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Animal Orthopedic Diseases Stem Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Animal Orthopedic Diseases Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Animal Orthopedic Diseases Stem Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Animal Orthopedic Diseases Stem Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Animal Orthopedic Diseases Stem Cell Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Animal Orthopedic Diseases Stem Cell Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Animal Orthopedic Diseases Stem Cell Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Animal Orthopedic Diseases Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Animal Orthopedic Diseases Stem Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Animal Orthopedic Diseases Stem Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Animal Orthopedic Diseases Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Animal Orthopedic Diseases Stem Cell Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Animal Orthopedic Diseases Stem Cell Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 47. MediVet Biologics Company Details
Table 48. MediVet Biologics Business Overview
Table 49. MediVet Biologics Animal Orthopedic Diseases Stem Cell Therapy Product
Table 50. MediVet Biologics Revenue in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 51. MediVet Biologics Recent Development
Table 52. Regeneus Company Details
Table 53. Regeneus Business Overview
Table 54. Regeneus Animal Orthopedic Diseases Stem Cell Therapy Product
Table 55. Regeneus Revenue in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 56. Regeneus Recent Development
Table 57. VetStem Company Details
Table 58. VetStem Business Overview
Table 59. VetStem Animal Orthopedic Diseases Stem Cell Therapy Product
Table 60. VetStem Revenue in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 61. VetStem Recent Development
Table 62. Tissue Regeneration Company Details
Table 63. Tissue Regeneration Business Overview
Table 64. Tissue Regeneration Animal Orthopedic Diseases Stem Cell Therapy Product
Table 65. Tissue Regeneration Revenue in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 66. Tissue Regeneration Recent Development
Table 67. ZyGenesis Company Details
Table 68. ZyGenesis Business Overview
Table 69. ZyGenesis Animal Orthopedic Diseases Stem Cell Therapy Product
Table 70. ZyGenesis Revenue in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 71. ZyGenesis Recent Development
Table 72. Vetsuisse Company Details
Table 73. Vetsuisse Business Overview
Table 74. Vetsuisse Animal Orthopedic Diseases Stem Cell Therapy Product
Table 75. Vetsuisse Revenue in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 76. Vetsuisse Recent Development
Table 77. Regenesis Biomedical Company Details
Table 78. Regenesis Biomedical Business Overview
Table 79. Regenesis Biomedical Animal Orthopedic Diseases Stem Cell Therapy Product
Table 80. Regenesis Biomedical Revenue in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 81. Regenesis Biomedical Recent Development
Table 82. Cegelec Company Details
Table 83. Cegelec Business Overview
Table 84. Cegelec Animal Orthopedic Diseases Stem Cell Therapy Product
Table 85. Cegelec Revenue in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 86. Cegelec Recent Development
Table 87. Boehringer Ingelheim Company Details
Table 88. Boehringer Ingelheim Business Overview
Table 89. Boehringer Ingelheim Animal Orthopedic Diseases Stem Cell Therapy Product
Table 90. Boehringer Ingelheim Revenue in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 91. Boehringer Ingelheim Recent Development
Table 92. Astellas Pharma Company Details
Table 93. Astellas Pharma Business Overview
Table 94. Astellas Pharma Animal Orthopedic Diseases Stem Cell Therapy Product
Table 95. Astellas Pharma Revenue in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 96. Astellas Pharma Recent Development
Table 97. Aratana Therapeutics Company Details
Table 98. Aratana Therapeutics Business Overview
Table 99. Aratana Therapeutics Animal Orthopedic Diseases Stem Cell Therapy Product
Table 100. Aratana Therapeutics Revenue in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 101. Aratana Therapeutics Recent Development
Table 102. Neogen Company Details
Table 103. Neogen Business Overview
Table 104. Neogen Animal Orthopedic Diseases Stem Cell Therapy Product
Table 105. Neogen Revenue in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 106. Neogen Recent Development
Table 107. Kite Pharma Company Details
Table 108. Kite Pharma Business Overview
Table 109. Kite Pharma Animal Orthopedic Diseases Stem Cell Therapy Product
Table 110. Kite Pharma Revenue in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 111. Kite Pharma Recent Development
Table 112. Juno Therapeutics Company Details
Table 113. Juno Therapeutics Business Overview
Table 114. Juno Therapeutics Animal Orthopedic Diseases Stem Cell Therapy Product
Table 115. Juno Therapeutics Revenue in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 116. Juno Therapeutics Recent Development
Table 117. Tianjin BION Biotechnology Company Details
Table 118. Tianjin BION Biotechnology Business Overview
Table 119. Tianjin BION Biotechnology Animal Orthopedic Diseases Stem Cell Therapy Product
Table 120. Tianjin BION Biotechnology Revenue in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 121. Tianjin BION Biotechnology Recent Development
Table 122. Amazing Pet Company Details
Table 123. Amazing Pet Business Overview
Table 124. Amazing Pet Animal Orthopedic Diseases Stem Cell Therapy Product
Table 125. Amazing Pet Revenue in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 126. Amazing Pet Recent Development
Table 127. Vetcell Company Details
Table 128. Vetcell Business Overview
Table 129. Vetcell Animal Orthopedic Diseases Stem Cell Therapy Product
Table 130. Vetcell Revenue in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 131. Vetcell Recent Development
Table 132. Boya Life Company Details
Table 133. Boya Life Business Overview
Table 134. Boya Life Animal Orthopedic Diseases Stem Cell Therapy Product
Table 135. Boya Life Revenue in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025) & (US$ Million)
Table 136. Boya Life Recent Development
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
Table 140. Authors List of This Report


List of Figures
Figure 1. Animal Orthopedic Diseases Stem Cell Therapy Picture
Figure 2. Global Animal Orthopedic Diseases Stem Cell Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Animal Orthopedic Diseases Stem Cell Therapy Market Share by Type: 2024 VS 2031
Figure 4. Totipotent Stem Cells Features
Figure 5. Pluripotent Stem Cells Features
Figure 6. Unipotent Stem Cells Features
Figure 7. Global Animal Orthopedic Diseases Stem Cell Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Animal Orthopedic Diseases Stem Cell Therapy Market Share by Application: 2024 VS 2031
Figure 9. Osteoarthritis Case Studies
Figure 10. Cartilage Injury Case Studies
Figure 11. Fracture Repair Case Studies
Figure 12. Femoral Head Necrosis Case Studies
Figure 13. Spinal Degenerative Diseases Case Studies
Figure 14. Others Case Studies
Figure 15. Animal Orthopedic Diseases Stem Cell Therapy Report Years Considered
Figure 16. Global Animal Orthopedic Diseases Stem Cell Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Animal Orthopedic Diseases Stem Cell Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Animal Orthopedic Diseases Stem Cell Therapy Market Share by Region: 2024 VS 2031
Figure 19. Global Animal Orthopedic Diseases Stem Cell Therapy Market Share by Players in 2024
Figure 20. Global Animal Orthopedic Diseases Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. The Top 10 and 5 Players Market Share by Animal Orthopedic Diseases Stem Cell Therapy Revenue in 2024
Figure 22. North America Animal Orthopedic Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Animal Orthopedic Diseases Stem Cell Therapy Market Share by Country (2020-2031)
Figure 24. United States Animal Orthopedic Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Animal Orthopedic Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Animal Orthopedic Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Animal Orthopedic Diseases Stem Cell Therapy Market Share by Country (2020-2031)
Figure 28. Germany Animal Orthopedic Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Animal Orthopedic Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Animal Orthopedic Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Animal Orthopedic Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Animal Orthopedic Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Animal Orthopedic Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Animal Orthopedic Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Animal Orthopedic Diseases Stem Cell Therapy Market Share by Region (2020-2031)
Figure 36. China Animal Orthopedic Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Animal Orthopedic Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Animal Orthopedic Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Animal Orthopedic Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Animal Orthopedic Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Animal Orthopedic Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Animal Orthopedic Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Animal Orthopedic Diseases Stem Cell Therapy Market Share by Country (2020-2031)
Figure 44. Mexico Animal Orthopedic Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Animal Orthopedic Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Animal Orthopedic Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Animal Orthopedic Diseases Stem Cell Therapy Market Share by Country (2020-2031)
Figure 48. Turkey Animal Orthopedic Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Animal Orthopedic Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Animal Orthopedic Diseases Stem Cell Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. MediVet Biologics Revenue Growth Rate in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025)
Figure 52. Regeneus Revenue Growth Rate in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025)
Figure 53. VetStem Revenue Growth Rate in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025)
Figure 54. Tissue Regeneration Revenue Growth Rate in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025)
Figure 55. ZyGenesis Revenue Growth Rate in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025)
Figure 56. Vetsuisse Revenue Growth Rate in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025)
Figure 57. Regenesis Biomedical Revenue Growth Rate in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025)
Figure 58. Cegelec Revenue Growth Rate in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025)
Figure 59. Boehringer Ingelheim Revenue Growth Rate in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025)
Figure 60. Astellas Pharma Revenue Growth Rate in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025)
Figure 61. Aratana Therapeutics Revenue Growth Rate in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025)
Figure 62. Neogen Revenue Growth Rate in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025)
Figure 63. Kite Pharma Revenue Growth Rate in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025)
Figure 64. Juno Therapeutics Revenue Growth Rate in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025)
Figure 65. Tianjin BION Biotechnology Revenue Growth Rate in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025)
Figure 66. Amazing Pet Revenue Growth Rate in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025)
Figure 67. Vetcell Revenue Growth Rate in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025)
Figure 68. Boya Life Revenue Growth Rate in Animal Orthopedic Diseases Stem Cell Therapy Business (2020-2025)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’